Chromosomal abnormalities and related events in prostate cancer

Human Pathology

Volumn 23, Issue 4, 1992, Pages 368-380

  Sandberg, Avery A ^a  

^a Southwest Biomedical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME POLYMORPHISM; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FAMILIAL DISEASE; HETEROCHROMATIN; HETEROZYGOSITY; HUMAN; IN SITU HYBRIDIZATION; KARYOTYPE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; SUPPRESSOR GENE;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; GROWTH SUBSTANCES; HUMAN; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0026650731     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(92)90083-F     Document Type: Article

References (88)

1. Cancer statistics 1990
2. Trends in cancer mortality
3. Chromosomal analysis in prostatic disease
4. Genetic and cytogenetic aspects of human prostate cancer
5. Growth in semisolid agar of prostate cancer cells obtained from bone marrow aspirates
6. An improved technique for short-term culturing of human prostatic adenocarcinoma tissue for cytogenetic analysis
7. Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: Diagnosis of trisomy 18 with probe L1.84
8. Bi-color detection of two target DNAs by non-radioactive in situ hybridization
9. The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology
10. Chromosome rearrangements in a metastatic adenocarcinoma of the prostate
11. Chromosome study of five cancers of the prostate
12. Chromosome 10 deletion in carcinoma of the prostate
13. Cytogenetic analysis of four primary prostatic cultures
14. Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma
15. Multiple structural chromosome rearrangements including del(7q) and del(10q), in an adenocarcinoma of the prostate
16. Double minutes in two primary adenocarcinomas of the prostate
17. Cytogenetic study of four cancers of the prostate
18. The chromosomes and causation of human cancer and leukemia. XIX. Common markers in various tumors
19. Evaluation of the bones and bone marrow in patients with metastatic carcinoma of the prostate: Radiologic, cytologic and cytogenetie findings
20. Isochromosome 17 in prostatic cancer
21. A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP)
22. Flow cytometric and karyotypic analysis of a primary small cell carcinoma of the prostate: A xenografted cell line
23. Cytogenetic analysis of 57 primary prostatic adenocarcinomas
24. AgNOR staining in benign hyperplasia and carcinoma of the prostate
25. Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients
26. Isolation of a human prostate carcinoma cell line (DU 145)
27. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
28. LNCaP model of a human prostatic carcinoma
29. Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice
30. Human prostatic adenocarcinoma: Some characteristics of a serially transplantable line in nude mice
31. Establishment of a new prostatic carcinoma cell line (TSU-PR-1)
32. Cytogenetic characterization of androgen-responsive and -unresponsive sublines of the human prostatic carcinoma cell line LNCaP
33. Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82)
34. Frequency and pattern of karyotypic abnormalities in human prostate cancer
35. Chromosomal analysis of human prostatic adenocarcinoma cell lines
36. Clonal growth characteristics of adult human prostatic epithelial cells
37. Allelic loss of chromosomes 16q and 10q in human prostate cancer
38. Metastatic diversity in human prostatic carcinoma: Implications of growth factors and growth factor receptors for the metastatic phenotype
39. The endocrinology and developmental biology of the prostate
40. Metastasis suppressor genes
41. The approaching era of the tumor suppressor genes
42. Critical factors in the biology of human cancer metastasis: Twenty-eight G.H.A. Clowes Memorial Award Lecture
43. Do genes help regulate metastasis?
44. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinoma with lymph node involvement and other histopathological indicators of high metastatic potential
45. Reduced nm23/awd protein in tumour metastasis and aberrant drosophila development
46. Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis
47. Some epidemiological variables in prostatic carcinoma in California
48. Epidemiologic evidence regarding predisposing factors to prostate cancer
49. Reviews: Prostate cancer epidemiology
50. An investigation of the familial aspects of cancer of the prostate
51. Epidemiological study of prostatic cancer analysis
52. Prostatic carcinoma at autopsy in Hiroshima and Nagasaki Japanese
53. Occupation and prostatic cancer. A review and retrospective analysis based on death certificates in two California counties
54. Physical and demographic features of men before developing cancer of the prostate
55. Epidemiology of cancer of the prostate
56. Some epidemiological aspects of cancer of the prostate
57. Epidemiologic characteristics of patients with prostatic neoplasms
58. Studies in the epidemiology of prostatic cancer. Expanded sampling
59. Groups of variables available for prevention of prostatic cancer
60. Epidemiologic study of prostatic cancer: Preliminary report
61. Sexual factors in the epidemiology of cancer of the prostate
62. Relation between benign prostatic hyperplasia and cancer of the prostate
63. Cancer of the prostate among men with benign prostatic hyperplasia
64. Prostate cancer epidemiology: Widowhood and cancer in spouses
65. Diet in the epidemiology of carcinoma of the prostate gland
66. Nutrient intakes in relation to cancer incidence in Hawaii
67. Epidemiology of prostate cancer with special reference to the role of diet
68. Epidemiology of prostatic cancer: A case-control study
69. Prostate cancer occurring in identical twins: A case report
70. Family history and the risk of prostate cancer
71. Adenocarcinoma of the prostate in a 41-year-old man with XXY karyotype and chronic lymphocytic leukemia: Report of a case
72. Chromosome 1 heteromorphism in patients with malignant disease: A constitutional marker for a high risk group?
73. Constitutive heterochromatin C-band polymorphism in prostatic cancer
74. Negative growth controls and carcinogenesis
75. Oncogenes in growth and development
76. Genetic alteration during colorectal-tumor development
77. Cytogenetic evaluation of 20 cultured primary prostatic tumors
78. Alterations of the p53 gene are associated with the progression of a human prostate carcinoma
79. p53, c-erB-2 and the epidermal growth factor receptor in the benign and malignant prostate
80. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
81. Activated ras alleles in human carcinoma of the prostate are rare
82. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma
83. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
84. Promoter deletion and loss of retinoblastoma gene expression human prostate carcinoma
85. Familial patterns of prostate cancer: A case-control analysis